Svoronos Dawn
Related Filers (7)
- PTC THERAPEUTICS, INC. (13)
- MEDIVATION, INC. (12)
- Xenon Pharmaceuticals Inc. (12)
- Global Blood Therapeutics, Inc. (8)
- Adverum Biotechnologies, Inc. (7)
- ENDOCYTE INC (3)
- ACELYRIN, Inc. (3)
- Show More ...
Ownership (57)
4
Thursday, 8/24/2023
Xenon Pharmaceuticals Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/13/2023
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/2/2023
Xenon Pharmaceuticals Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/11/2023
ACELYRIN, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 5/4/2023
ACELYRIN, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 5/4/2023
ACELYRIN, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/6/2022
Global Blood Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/29/2022
Xenon Pharmaceuticals Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/22/2022
Global Blood Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/16/2022
Global Blood Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/14/2022
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/10/2022
PTC THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/18/2022
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/11/2022
PTC THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 6/21/2021
Global Blood Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/11/2021
PTC THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/3/2021
Xenon Pharmaceuticals Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/14/2021
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/1/2021
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/2/2021
PTC THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 1/8/2021
PTC THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
3
Friday, 12/11/2020
Adverum Biotechnologies, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 12/11/2020
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/19/2020
Global Blood Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/12/2020
PTC THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/2/2020
Xenon Pharmaceuticals Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/31/2020
PTC THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/18/2019
Xenon Pharmaceuticals Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/20/2019
Global Blood Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/24/2019
PTC THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
3
Friday, 12/21/2018
Global Blood Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 12/21/2018
Global Blood Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/21/2018
ENDOCYTE INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/5/2018
Xenon Pharmaceuticals Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 5/4/2018
ENDOCYTE INC: Initial statement of beneficial ownership of securities
4
Friday, 5/4/2018
ENDOCYTE INC: Statement of changes in beneficial ownership of securities
4
Friday, 1/5/2018
PTC THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/15/2017
Xenon Pharmaceuticals Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/2/2017
Xenon Pharmaceuticals Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/24/2017
PTC THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2017
PTC THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 9/30/2016
MEDIVATION, INC.: Statement of changes in beneficial ownership of securities
3
Tuesday, 9/27/2016
Xenon Pharmaceuticals Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 9/27/2016
Xenon Pharmaceuticals Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/23/2016
MEDIVATION, INC.: Statement of changes in beneficial ownership of securities
3
Monday, 6/13/2016
PTC THERAPEUTICS, INC.: Initial statement of beneficial ownership of securities
4
Monday, 6/13/2016
PTC THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/16/2016
MEDIVATION, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/8/2015
MEDIVATION, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/18/2015
MEDIVATION, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/4/2015
MEDIVATION, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/16/2014
MEDIVATION, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/1/2014
MEDIVATION, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/2/2013
MEDIVATION, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/30/2013
MEDIVATION, INC.: Statement of changes in beneficial ownership of securities
3
Tuesday, 4/23/2013
MEDIVATION, INC.: Initial statement of beneficial ownership of securities
4
Tuesday, 4/23/2013
MEDIVATION, INC.: Statement of changes in beneficial ownership of securities